Athira Pharma ATHA 深 滬
等待開盤 09-20 09:30:00 美东时间
0.4649
+0.002
+0.41%
華盛通- 最 高0.4789
- 今 開0.47
- 成交量 90.29万股
- 最 低 0.46
- 昨 收 0.463
- 總市值 1781.81万
- 52周最高 4.2984
- 市盈率 靜 --
- 換手率 2.36%
- 52周最低 0.46
- 委 比 -41.52%
- 總股本 3832.67万
- 歷史最高 34.79
- 量 比 0.99
- 振 幅 4.08%
- 歷史最低 0.46
- 每 手 1
- 風險率 0.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | Athira Pharma Inc：杰富瑞将目标价从3美元下调至0.5美元
Athira Pharma Inc : Jefferies Cuts Target Price to $0.5 From $3
09-18 12:36
3 Penny Stocks to Watch Now, 9/05/24
Athira Pharma, Tonix Pharma, and iLearningEngines Holdings are the 3 Penny Stoc...
09-05 21:15
Athira plunges as Alzheimer’s trial setback leads to downgrades
Athira Pharma (NASDAQ:ATHA) shares fell over 75% after the company said fosgonimeton, its experimental therapy for Alzheimer's disease, failed in a Phase 2/3 trial, prompting at least two Wall Street ...
09-05 03:37
BTIG Downgrades Athira Pharma to Neutral
BTIG analyst Thomas Shrader downgrades Athira Pharma (NASDAQ:ATHA) from Buy to Neutral.
09-04 22:36
Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Shares of GitLab Inc. (NASDAQ:GTLB) rose sharply in today's pre-market trading ...
09-04 18:39
阿尔茨海默症药物Fosgonimeton临床试验失利，Athira Pharma(ATHA.US)盘后暴跌72%
Athira Pharma治疗阿尔茨海默氏症的候选药物fosgonimeton在2/3期临床试验中未能达到主要终点和关键次要终点。
09-04 14:33
Athira stock craters 72% on failed study for Alzheimer's drug
Athira Pharma (NASDAQ:ATHA) stock cratered 72% in post-market trading Tuesday after the company announced that a Phase 2/3 study of its drug Alzheimer’s drug candidate fosgonimeton failed to meet its ...
09-04 05:12
Terra Uranium Forms Joint Venture with ATHA Energy
Terra Uranium Limited (AU:T92) has released an update. Terra Uranium Limited ha...
08-20 08:28
